The annual number of liver transplantation operations increases when transplantation centers are concentrated in geographic areas that are highly competitive, according to findings from a new study published as an "article in press" in the Journal of the American College of Surgeons (JACS). The study, believed to be the first one to demonstrate a link between the volume of liver transplantation and competition for organs and geographic density, will appear in the print edition of the Journal this summer.
Researchers from the Department of Surgery and the Center for Surgery and Public Health at Brigham and Women's Hospital, Boston, retrospectively assessed the effects of market competition and liver transplant center density on the number and outcomes of 53,156 adult liver transplantation operations performed across the United States between 2003 and 2012.
"As we have shown in other studies that apply economic theory and analysis to clinical questions, hospitals and surgeons in competitive markets do things that are more cutting edge and innovative, and that benefit patients by increasing access to advanced techniques and services. But classic market competitive analysis does not take geography into consideration, and in medicine, hospital location and distance traveled to that location can affect the care patients receive and their outcomes," according to study coauthor and associate professor of surgery at Harvard Medical School Louis L. Nguyen, MD, MBA, MPH, FACS.
"This study merges data about the market share and geographic distribution of liver transplantation centers to better understand the way they may affect the use of scarce resources and contribute to the uneven distribution of donor organs in the U.S.," Dr. Nguyen said.
Liver transplantation is a life-saving operation for many patients who have end-stage liver disease because of hepatitis, primary liver cancer, alcoholism, or hepatitis associated with obesity. The five-year survival rate for patients who undergo the procedure is 75 to 80 percent, according to lead author and surgical resident Joel T. Adler, MD, MPH. However, there are wide geographic disparities in access to liver transplantation. More than 1,500 candidates for the operation die each year waiting for a liver transplant and another 1,500 are removed from waiting lists because they are considered to be too ill to have the transplant procedure, according to the Organ Procurement and Transplantation Network (OPTN), a division of the Health Resources and Services Administration.
The researchers collected information about liver transplant centers in each of the country's 45 donation service areas (DSAs) with liver transplant centers. DSAs define the areas in which organs are allocated and donated, explained Dr. Adler. In addition to clinical variables associated with patient outcomes, the study assessed two aspects of economic performance--the degree of market competitiveness and the concentration of transplantation centers, or density, in each DSA.
As a result of sophisticated statistical regressions, the annual number of liver transplantations was higher in more competitive DSAs--the incidence rate ratio (IRR) was 1.36 and P value was 0.02--and transplant center density was linked with market competition (P<0.0001). The annual number of liver transplantations was lower in less densely concentrated DSAs, such as those with only one transplantation center (IRR 0.81, P=0.001). Market competition and density had no effect on patient mortality.
Dr. Nguyen acknowledged that his research team did not set out with the goal of addressing geographic disparity in organ distribution. "We are trying to provide an analytical approach to understand access to transplantation and shed light on economic factors that were previously hard to analyze but are important in understanding what happens in transplantation," he said.
However, the model the Brigham and Women's research team is developing could offer information to policymakers, such as OPTN, who are examining issues related to the allocation of organs.
"Every year patients die of liver failure who don't get a transplant. So how can we improve the situation? Do we increase the number of transplant centers? Do we change the way that we allocate these organs? Do we change the boundaries of DSAs and the system of distribution? Our model can help decision-makers assess their options and see what can potential happen.. It allows us to see the implications of not just adding another transplant center, but specifically where it is located relative to other centers," Dr. Nguyen concluded.
Materials provided by American College of Surgeons. Note: Content may be edited for style and length.
Cite This Page: